Medicine recalls
|
| |
| Batch Recall of Genteal Eye Gel |
| |
The Department of Health (DH) today (April 28) endorsed a licensed drug wholesaler, namely Healthcare Division O/B DCH Auriga (Hong Kong) Limited (DCH Auriga), the distributor appointed by Alcon Hong Kong Ltd. (Alcon), to voluntarily recall one batch (batch number: 5V83) of the pharmaceutical product, namely Genteal Eye Gel from the market as a precautionary measure due to potential quality issues.
The DH received notification from Alcon that the overseas manufacturer of the product is recalling the above batch of Genteal Eye Gel due to potential issues at the manufacturing site that may affect the quality of multidose ophthalmic products.
The above product, containing hydroxypropyl methylcellulose (hypromellose) 0.3% w/w, is an over-the-counter medicine indicated for the treatment dry eye condition. The affected batch of the product is not registered pharmaceutical product but was imported for the treatment of particular patients by the Hospital Authority (HA). According to Alcon, the affect batch was imported into Hong Kong and supplied solely to the HA.
Alcon has set up a hotline (2161 0848) to answer related enquiries.
So far, the DH has not received any adverse reaction reports in connection with the above product. The DH will closely monitor the recall.
Patients who have used the above product should consult their healthcare professionals if in doubt.
Ends/ Tuesday, 28 April 2026
|
| |
